Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Royalty Pharma plc Director's Dealing 2023

May 16, 2023

30286_dirs_2023-05-15_89bd2ae4-beb2-4f5d-b80a-18b5beb6da43.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Royalty Pharma plc (RPRX)
CIK: 0001802768
Period of Report: 2023-05-12

Reporting Person: Legorreta Pablo G. (Director, CEO, Chairman of the Board, 10% Owner)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2023-05-12 ICAI Interests $0 G 10269 Disposed Limited Partnership interests in RPI US Partners 2019, LP (10269) Indirect
2023-05-12 ICAI Interests $0 G 10269 Acquired Limited Partnership interests in RPI US Partners 2019, LP (10269) Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
ICAI Interests $0 Limited Partnership interests in RPI US Partners 2019, LP (1007488) 1007488 Indirect

Footnotes

F1: Reflects an exempt gift for no consideration of ICAI Interests from the reporting person's spouse to the reporting person.

F2: These ICAI Interests represent a beneficial interest in an equivalent number of limited partnership interests ("RPI US LP Interests") in RPI US Partners 2019, LP ("RPI US LP") and may be exchanged into RPI US LP Interests on a one-for-one basis currently. The ICAI Interests do not have an expiration date.

F3: Represents RPI US LP Interests. Each RPI US LP Interest can be exchanged for ten Class B Interests in Holdings at any time and for no additional value, which exchange right does not expire until so converted. Each Class B Interest in Holdings issued in exchange for a RPI US LP Interest will be exchanged upon such exchange for one Class A Ordinary Share of the Issuer for no additional value.

F4: Reflects the exempt change in the form of beneficial ownership without a change in the reporting person's pecuniary interest pursuant to Rule 16a-13 of certain ICAI Interests from being directly or indirectly owned by the reporting person through Legorreta Investments II LLC to being directly owned or indirectly owned through Legorreta Investments LLC and the reporting person's spouse.